Treatment for severe acute respiratory illness associated with coronavirus
- Resource Type
- Patent
- Authors
- Source
- Subject
- Language
A method is provided for identifying a patient having a respiratory illness and administering to the patient a combination of an anti-inflammatory agent and a leukotriene inhibitor. The method may include treating respiratory illness associated with a coronavirus, and may it may further include reducing or preventing an inflammatory response or cytokine storm for those patients without impairing their immune response against the underlying pathogen.